ARGX 股價走勢圖
ARGX 股票價格預測
argenx SE
$813.28
3.97%
$31.11
收盤價：May 11, 16:00:00 GMT-4
$801.5
-1.44%
$-11.77
盤前：May 12, 07:02:59 GMT-4
返回
argenx SE (ARGX) 股票價格預測
關鍵數據
前收市價
$782.17
開盤價
$809.8
當日範圍
$795.98 - $827.8
52週區間
$510.05 - $934.62
交易量
492.4K
平均成交量
337.5K
股息收益率
--
每股盈餘 (TTM)
19.59
市值
$49.8B
什麼是 argenx SE？
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland. The company went IPO on 2014-07-10. The company is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.
